Clinical Trial Update: Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel with or without vandetanib in metastatic gastric cancer and gastroesophageal junction cancer was terminated; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vandetanib (vandetanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-01-08